Sept 30 (Reuters) - Discovery Laboratories Inc:
* Labs and FDA establish path for potential Surfaxin approval
* Says FDA indicated company's proposed program to optimize and validate a
quality control test is reasonable
* Sees to finalize a protocol, anticipates submitting it to FDA in mid-Q4 of
狗仔卡
发表于 2009-9-30 07:20 AM
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡